Similar Posts
Rambam Physicians Perform Life-changing Orthopedic Surgeries in Georgia
December 8, 2024 – Medical practice knows no borders connecting cultures, beliefs, and worldviews. Recently, two physicians from Rambam Health Care Campus (Rambam) in Haifa, Israel, traveled to Georgia to perform specialized orthopedic surgeries on patients from Jordan, Greece, Ukraine, and Russia. To reach populations that lack access to specialized medical expertise, Professor Mark Eidelman,…
Fitness Equipment Placed in Isolation Rooms for Children Undergoing Bone Marrow Transplantation
May 12, 2022 – “The exercise equipment will enable children undergoing bone marrow transplantation to be as physically active as their conditions will allow, helping them to stay busy and improve their health,” notes Dr. Shifra Ash, Director of the Joan & Sanford Weill Division of Pediatric Hematology-Oncology and Bone Marrow Transplantation. Rambam’s Ruth Rappaport…
Against All Odds: A Rare High-Risk Pregnancy
July 13, 2026 – Lior and Aviv Zucker faced an impossible decision—to terminate a rare, high-risk pregnancy or continue despite the significant danger to their unborn babies. Choosing hope, and guided by an expert multidisciplinary team at Rambam Health Care Campus (Rambam) in Haifa, Lior went on to deliver two healthy baby girls. Lior Zucker…
Micro and Nanoplastics in the Body Increase the Risk for Heart Attacks and Strokes
April 7, 2024 — A recent study has found that micro and nanoplastic particle accumulation in the human body is directly correlated to the risk for cardiovascular disease and strokes. A cardiovascular expert from Rambam Health Care Campus (Rambam) in Haifa, Israel provides insight on the importance of this study. A recent study published in the…
First in Israel: Gene-Editing Therapy for Heart Failure
August 26, 2025 – For the first time in Israel, Rambam Health Care Campus (Rambam) is testing a revolutionary gene-editing treatment that could halt a deadly form of heart failure. The same technology may soon target another global killer: high cholesterol. In collaboration with Intellia Therapeutics, a U.S. biotech company, Rambam is conducting the first…
Rambam Physician Discovers New Cause of Vision Loss in Diabetics
Professor Shehadeh, Director of Rambam’s Diabetes Institute, found that vision is impaired in hyperglycemic people exposed to certain light wavelengths. Special eyeglasses for diabetic patients will be tested. Diabetes is the leading cause of new vision loss in working-age adults (20-60 years old) worldwide. Israel is at the cutting edge in diabetes research, with the…
